| Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: a review M Kanamala, WR Wilson, M Yang, BD Palmer, Z Wu Biomaterials 85, 152-167, 2016 | 967 | 2016 |
| Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer’s disease Q Meng, A Wang, H Hua, Y Jiang, Y Wang, H Mu, Z Wu, K Sun International journal of nanomedicine, 705-718, 2018 | 290 | 2018 |
| Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models Y Chi, X Yin, K Sun, S Feng, J Liu, D Chen, C Guo, Z Wu Journal of Controlled Release 261, 113-125, 2017 | 223 | 2017 |
| Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson’s disease treatment C Bi, A Wang, Y Chu, S Liu, H Mu, W Liu, Z Wu, K Sun, Y Li International journal of nanomedicine, 6547-6559, 2016 | 205 | 2016 |
| Differences in metabolite profile between blood plasma and serum L Liu, J Aa, G Wang, B Yan, Y Zhang, X Wang, C Zhao, B Cao, J Shi, M Li, ... Analytical biochemistry 406 (2), 105-112, 2010 | 187 | 2010 |
| Advances in rectal drug delivery systems TJ Purohit, SM Hanning, Z Wu Pharmaceutical development and technology 23 (10), 942-952, 2018 | 151 | 2018 |
| Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticles for treating Parkinson’s disease S Tang, A Wang, X Yan, L Chu, X Yang, Y Song, K Sun, X Yu, R Liu, Z Wu, ... Drug Delivery 26 (1), 700-707, 2019 | 144 | 2019 |
| Strategies to enhance drug delivery to solid tumors by harnessing the EPR effects and alternative targeting mechanisms Y Zi, K Yang, J He, Z Wu, J Liu, W Zhang Advanced Drug Delivery Reviews 188, 114449, 2022 | 126 | 2022 |
| Nose-to-brain delivery of temozolomide-loaded PLGA nanoparticles functionalized with anti-EPHA3 for glioblastoma targeting L Chu, A Wang, L Ni, X Yan, Y Song, M Zhao, K Sun, H Mu, S Liu, Z Wu, ... Drug delivery 25 (1), 1634-1641, 2018 | 125 | 2018 |
| Conjunctival and corneal tolerability assessment of ocular naltrexone niosomes and their ingredients on the hen's egg chorioallantoic membrane and excised bovine cornea models H Abdelkader, S Ismail, A Hussein, Z Wu, R Al-Kassas, RG Alany International journal of pharmaceutics 432 (1-2), 1-10, 2012 | 105 | 2012 |
| Niosomes and discomes for ocular delivery of naltrexone hydrochloride: morphological, rheological, spreading properties and photo-protective effects H Abdelkader, Z Wu, R Al-Kassas, RG Alany International journal of pharmaceutics 433 (1-2), 142-148, 2012 | 99 | 2012 |
| Nanoparticle-mediated cytoplasmic delivery of messenger RNA vaccines: challenges and future perspectives Z Wu, T Li Pharmaceutical Research 38 (3), 473-478, 2021 | 96 | 2021 |
| Conducting polymer hydrogels for electrically responsive drug delivery M Bansal, A Dravid, Z Aqrawe, J Montgomery, Z Wu, D Svirskis Journal of controlled release 328, 192-209, 2020 | 96 | 2020 |
| Protective effects of ginsenoside Rb3 on oxygen and glucose deprivation-induced ischemic injury in PC12 cells J Zhu, Y Tao, S Lou, Z Wu Acta Pharmacologica Sinica 31 (3), 273-280, 2010 | 91 | 2010 |
| Pharmacokinetics and atherosclerotic lesions targeting effects of tanshinone IIA discoidal and spherical biomimetic high density lipoproteins W Zhang, H He, J Liu, J Wang, S Zhang, S Zhang, Z Wu Biomaterials 34 (1), 306-319, 2013 | 90 | 2013 |
| Optimization of the formation of embedded multicellular spheroids of MCF-7 cells: How to reliably produce a biomimetic 3D model W Zhang, C Li, BC Baguley, F Zhou, W Zhou, JP Shaw, Z Wang, Z Wu, ... Analytical biochemistry 515, 47-54, 2016 | 86 | 2016 |
| Metabolomic approach to evaluating adriamycin pharmacodynamics and resistance in breast cancer cells B Cao, M Li, W Zha, Q Zhao, R Gu, L Liu, J Shi, J Zhou, F Zhou, X Wu, ... Metabolomics 9, 960-973, 2013 | 86 | 2013 |
| Photosensitive drug delivery systems for cancer therapy: Mechanisms and applications P Pan, D Svirskis, SWP Rees, D Barker, GIN Waterhouse, Z Wu Journal of Controlled Release, 2021 | 82 | 2021 |
| Engineering of bone-and CD44-dual-targeting redox-sensitive liposomes for the treatment of orthotopic osteosarcoma S Feng, ZX Wu, Z Zhao, J Liu, K Sun, C Guo, H Wang, Z Wu ACS applied materials & interfaces 11 (7), 7357-7368, 2019 | 80 | 2019 |
| Dual pH-sensitive liposomes with low pH-triggered sheddable PEG for enhanced tumor-targeted drug delivery M Kanamala, BD Palmer, SMF Jamieson, WR Wilson, Z Wu Nanomedicine 14 (15), 1971-1989, 2019 | 77 | 2019 |
Darren SvirskisUniveristy of AucklandDirección de correo verificada de auckland.ac.nz
